ABOUT NEUROASPIS

NEUROASPIS® plp10 is a cocktail food supplement oral formula that has been specifically designed to overcome the well known biochemical deficiencies of the MS patients which are found related to the disease pathophysiology including recovery; and it has been tested through a proof of concept clinical study performed from July 2007 until December 2010. The preparation has been specifically designed by a team of three committed and highly specialized scientists (Dr. Patrikios I. Mr. Loukaides G. and Dr. Pantzaris M.) in the field of Neurology, Medical Biochemistry, Immunology, Lipidology,  and Clinical Nutrition and produced in accordance to the innovative method of treatment philosophy and approach, the systems medicine, through systems biology.

CLINICAL STUDIES

A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial >>

PUBLICATIONS

More than forty five Supportive Statements and Publications about NEUROASPIS since 1997 >>

LATEST NEWS

23.02.2018 NEUROASPIS LAUNCH IN CZECH REPUBLIC

Aniva Int. reached an agreement for the launch of its brand NEUROASPIS (the first supplement with Clinical Study and World Patent for Multiple Sclerosis and related Neurodegenerative diseases) in Czech Republic through a specialized company in health care of patients with neurological disorders. This agreement comes after the launch of Neuroaspis in Slovakia and ongoing discussions in […]

28.11.2017 NEUROASPIS® plp10 at XI/XVII Congress of Serbian Neurologists with International Participation

NEUROASPIS® plp10 was presented at XI/XVII Congress of Serbian Neurologists with International Participation will was held in Belgrade from 24 to 26.11.2017 .